12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Anavex preclinical data

In a non-transgenic mouse model of AD, 300 µg/kg ANAVEX 2-73 reversed learning deficits associated with injection of the beta amyloid...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >